4D Molecular Therapeutics is a startup based in the United States, most recent round Series-c-plus, 1 tracked investor.
Based in the United States, 4D Molecular Therapeutics is a startup. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
4D Molecular Therapeutics is a platform company that discovers and develops novel adeno-associated virus (AAV) vectors for use in gene therapy products. Its work is focused on creating AAV-based approaches to treat monogenic (single-gene) disorders.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.